These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13365652)

  • 21. Compounds inhibiting insulin degradation.
    WILLIAMS RH
    Diabetes; 1957; 6(1):25-6; discussion, 30-2. PubMed ID: 13397415
    [No Abstract]   [Full Text] [Related]  

  • 22. Carbutamide and plasma insulin activity.
    VON HOLT C; VON HOLT L; KRACHT J; KRONER B; KUHNAU J
    Science; 1957 Apr; 125(3251):735-6. PubMed ID: 13421673
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of N-sulfanilyl-N'-butyl urea on blood sugar level, and phosphate, potassium and sodium level in meta-alloxan diabetes of dogs].
    BIBERGEIL H; MOHNIKE G
    Arzneimittelforschung; 1956 Jul; 6(7):391-3. PubMed ID: 13355703
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of substituted sulfonylureas on rat diaphragm and liver tissue.
    ASHMORE J; CAHILL GF; HASTINGS AB
    Diabetes; 1957; 6(1):26-7; discussion, 30-2. PubMed ID: 13397416
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of carbutamide on serum inorganic phosphate.
    DE VENANZI F
    Proc Soc Exp Biol Med; 1957 May; 95(1):33-4. PubMed ID: 13431978
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of carbutamide on the insulin content of the dog pancreas.
    ROOT MA
    Diabetes; 1957; 6(1):12-6; discussion, 19-20. PubMed ID: 13397411
    [No Abstract]   [Full Text] [Related]  

  • 27. Insulin secretion following carbutamide injections in normal dogs.
    FOA PP; GALANSINO G; POZZA G
    Proc Soc Exp Biol Med; 1956 Dec; 93(3):539-42. PubMed ID: 13389514
    [No Abstract]   [Full Text] [Related]  

  • 28. Studies on the mechanism of action of the sulfonylureas.
    FRITZ IB; LEVINE R; MORTON JV; WEINSTEIN M
    Metabolism; 1956 Nov; 5(6 Part 2):744-8. PubMed ID: 13378042
    [No Abstract]   [Full Text] [Related]  

  • 29. [Analysis of N' -sulfanilyl-N' -butyl urea tablets].
    VITALI M; PANCRAZIO G
    Farmaco Prat; 1956 Sep; 11(9):512-5. PubMed ID: 13414827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of nadisan (BZ 55) on blood sugar in dogs with resected pancreas].
    BECKER WH; BUDDECKE E; MULLER H
    Klin Wochenschr; 1956 Sep; 34(33-34):920-1. PubMed ID: 13368430
    [No Abstract]   [Full Text] [Related]  

  • 31. [The possibility of colorimetric determination of N-(4-methyl-benzolsulfonyl)-N'-butyl urea in blood].
    SPINGLER H
    Klin Wochenschr; 1957 May; 35(10):533-5. PubMed ID: 13450259
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sulphanyl-butyl-urea in the treatment of diabetes mellitus].
    TIBERIO P
    Riforma Med; 1957 Jan; 71(3):64-8. PubMed ID: 13421383
    [No Abstract]   [Full Text] [Related]  

  • 33. [Use of BZ 55].
    BAQUET R
    Maroc Med; 1956 Jul; 35(374):731-3. PubMed ID: 13368691
    [No Abstract]   [Full Text] [Related]  

  • 34. [Oral antidiabetics].
    DORIA G
    Boll Chim Farm; 1956 Oct; 95(10):427-31. PubMed ID: 13383078
    [No Abstract]   [Full Text] [Related]  

  • 35. Lessened insulin hypophosphatemia following N-sulfanilyl-N'-butylurea (BZ-55 or carbutamid).
    DANOWSKI TS; KUNKEL MH; MATEER FM; WEIGAND FA
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):325-7. PubMed ID: 13408248
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical experience with BZ55.
    ELLERY EA
    Can J Med Technol; 1956 Dec; 18(4):118-21. PubMed ID: 13374593
    [No Abstract]   [Full Text] [Related]  

  • 37. An oral drug for diabetes.
    O'DRISCOLL BJ
    J Ir Med Assoc; 1956 Oct; 39(232):106-9. PubMed ID: 13367545
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy in diabetes mellitus with N-1-sulphanylil-N 2 n-butyl urea].
    GIORDANO G; PENDE G; ROMANO PM
    Arch Maragliano Patol Clin; 1956 Oct; 12(5):971-6. PubMed ID: 13395711
    [No Abstract]   [Full Text] [Related]  

  • 39. [Morphological findings on the mode of action of oral antidiabetics].
    KRACHT J; VON HOLT C; VON HOLT L
    Endokrinologie; 1957; 34(3):129-46. PubMed ID: 13427715
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hypoglycemic action of sulfonamide compounds].
    BUTTURINI U
    G Clin Med; 1956 Sep; 37(9):1217-48. PubMed ID: 13384740
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.